Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial

We present a practical approach to prioritising repurposed drugs to evaluate in the context of clinical AD. We would like to thank our patient and public contributors and the wider investigator team.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_102227
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial

Gordon Wilcock, Eric Karran, Benjamin R. Underwood, Leah Mursaleen et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial

Gordon Wilcock, Eric Karran, Benjamin R. Underwood, Leah Mursaleen, O'Brien John Tiernan, Suzanne Reeves, Cecilia Olivares, Sabahat Iqbal, Ross Dunne, James R. Carpenter, Alastair D. Reith, Fiona Ducotterd, Laura Rizzo, CS Wong, Malhotra Paresh, Vanessa Raymont, Lon S. S Schneider, Rik Vandenberghe, Jeffrey L. Cummings, Catherine J. Mummery, Thomas D Parker
article en

Abstract

We present a practical approach to prioritising repurposed drugs to evaluate in the context of clinical AD. We would like to thank our patient and public contributors and the wider investigator team.

Alzheimer s & DementiaVol. 21(S5)
University of Southern California (US), Allen Institute for Brain Science (US), University of Nevada, Las Vegas (US), Imperial College Healthcare NHS Trust (GB), Greater Manchester Mental Health NHS Foundation Trust (GB), Manchester Academic Health Science Centre (GB), University of Manchester (GB), University of Oxford (GB), Cambridge School (PT), UK Dementia Research Institute (GB), Alzheimer’s Research UK (GB), Cambridgeshire and Peterborough NHS Foundation Trust (GB), Science Oxford (GB), VIB-KU Leuven Center for Brain & Disease Research (BE), NIHR Research Delivery Network (GB), Accenture (United Kingdom) (GB), Dementias Platform UK (GB), University College London (GB), Imperial College London (GB), University of Edinburgh (GB)
Openalex Percentile: Top 32%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.